| Addition of niacin to simvastatin fails to protect the heart and may increase stroke risk |
|
| Abbott: Abbott Laboratories (ABT) Niaspan failed to prevent heart attacks and may have boosted stroke risk in a U.S.-funded study that calls into question the benefit of raising good cholesterol to combat the leading cause of death. |